Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Axon Neuroscience

    Client Virtual Booth

    AXON NEUROSCIENCE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Axon Neuroscience
    Cyprus Flag
    Country
    Country
    Cyprus
    Address
    Address
    Arch. Makariou & Kalogreon 4 Nicolaides Sea View City Block C, 5th floor Office 506 6016 LARNACA
    Telephone
    Telephone
    +357 2425 2636
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.axon-neuroscience.eu/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    AXON Neuroscience to Present New Results from Phase II Clinical Study
    AXON Neuroscience to Present New Results from Phase II Clinical Study

    https://www.accesswire.com/657035/AXON-Neuroscience-to-Present-New-Results-from-Phase-II-Clinical-Study-at-2021-Alzheimers-Association-International-Conference

    ACCESSWIRE
    27 Jul 2021
    Share Share
    AXON Neuroscience to Present New Results from Phase II Clinical Study
    AXON Neuroscience to Present New Results from Phase II Clinical Study

    https://www.accesswire.com/657035/AXON-Neuroscience-to-Present-New-Results-from-Phase-II-Clinical-Study-at-2021-Alzheimers-Association-International-Conference

    ACCESSWIRE
    27 Jul 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    16 Jun 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    15 Jun 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    14 Jun 2021
    Share Share
    Axon Neuroscience to launch world's first crowdfunded vaccine against COVID-19 
    Axon Neuroscience to launch world's first crowdfunded vaccine against COVID-19 

    https://www.prnewswire.com/news-releases/axon-neuroscience-to-launch-worlds-first-crowdfunded-vaccine-against-covid-19-301133925.html

    PRNEWSWIRE
    18 Sep 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search